Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

Dr. Daniel R. Marshak

Member of the Compensation Committee

1957, US-American citizen
Member since 2018, elected until 2025


Ph.D in Biochemistry and Cell Biology, The Rockefeller University, New York, USA; Bachelor in Biochemical Sciences, Harvard University, Cambridge, USA

Professional background

2014 to present

Consultancy for various companies in the Life Sciences, Bio-Pharmaceutical, and Diagnostics industry. Consultant to RADx program of US Government DHHS/NIH/NIBIB for COVID-19 diagnostics

2006 – 2014

PerkinElmer, Inc., USA (NYSE: PKI)
In his last role as Senior Vice President and Chief Scientific Officer, he was responsible for all science and technology as well as research and development activities and also led several acquisitions during that time.

Additional positions at PerkinElmer:
President, Emerging Diagnostics, Waltham, USA and Shanghai, China
President, Greater China, Shanghai, China

2000 – 2006

Cambrex Corporation, USA (NYSE: CBM)
Vice President and Chief Technology Officer, Biotechnology
Vice President Research and Development, Biosciences

1994 – 2000

Sr. Vice President and Chief Scientific Officer, Osiris Therapeutics, Inc

1986 – 1995

Cold Spring Harbor Laboratory, USA
Sr. Staff Investigator

1984 – 1986

Staff Fellow, National Institutes of Health, USA

Other activities

RareCyte, Inc.2, Member of the Board of Directors

2 private company